Dr. Norden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Albany St Suite 7b
Shapiro Bldg
Boston, MA 02118Phone+1 617-638-8456Fax+1 617-638-8465
Education & Training
Massachusetts General HospitalFellowship, Neuro-Oncology, 2006 - 2007
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2003 - 2006- Brigham and Women's HospitalInternship, Internal Medicine, 2002 - 2003
Yale School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2022 - 2026
IA State Medical License 2022 - 2026
ME State Medical License 2022 - 2026
TX State Medical License 2021 - 2026
VA State Medical License 2023 - 2026
CT State Medical License 2011 - 2025
GA State Medical License 2022 - 2025- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Clinical Trials
- Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) Start of enrollment: 2009 Jan 01
- Bosutinib in Adult Patients With Recurrent Glioblastoma Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- 143 citationsWatson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor boardS. P. Somashekhar, Martín-José Sepúlveda, S. Puglielli, Andrew D. Norden, Edward H. Shortliffe
Annals of Oncology. 2018-02-01 - 78 citationsAn Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer.Mark Stewart, Andrew D. Norden, Nancy A Dreyer, Henry J. Henk, Amy P. Abernethy
JCO Clinical Cancer Informatics. 2019-07-23 - 1009 citationsExciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant GliomaErwin G. Van Meir, Constantinos G. Hadjipanayis, Andrew D. Norden, Hui-Kuo G. Shu, Patrick Y. Wen
CA. 2010-05-01
Abstracts/Posters
- The Unforeseen Medical and Business Challenges Found When Integrating Abstracted Data from Disparate EHR Systems While Building the Curecloud Direct-to-Patient Multipl...Andrew D Norden, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple MyelomaAndrew D Norden, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Treatment patterns and outcomes among t(11;14) myeloma patients in a real-world setting.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Other
- Uncommon brain tumorsNorden AD, Chheda MG, Wen PY
http://www.uptodate.com/contents/uncommon-brain-tumors
UpToDate, Wolters Kluwer Health - 2013-02-28 - Secondary involvement of the central nervous system by non-Hodgkin lymphomaNorden AD, Hochberg E, Hochberg FH
http://www.uptodate.com/contents/secondary-involvement-of-the-central-nervous-system-by-non-hodgkin-
UpToDate, Wolters Kluwer Health - 2012-11-26
Press Mentions
Point32Health, OncoHealth Launch Cancer Telehealth PilotJune 17th, 2022
Oncology Analytics Appoints Dr. Andrew Norden as Chief Medical OfficerMay 21st, 2020
Real-World Data Reveals Quality Gaps in Routine Cancer CareFebruary 24th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
